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We tested the hypothesis that the change from the
peak to recovery values of systolic arterial pressure
(SAPrecovery) and rate–pressure product (RPPrecovery) can
be used to predict all-cause and cardiovascular morta-
lity, as well as sudden cardiac death (SCD) in patients
referred to a clinical exercise stress test. As a part of the
Finnish Cardiovascular Study (FINCAVAS), consecutive
patients (n¼ 2029; mean age±SD¼ 57±13 years; 1290
men and 739 women) with a clinically indicated exercise
test using a bicycle ergometer were included in the
present study. Capacities of attenuated SAPrecovery,
RPPrecovery and heart rate recovery (HRR) to stratify the
risk of death were estimated. During a follow-up
(mean±s.d.) of 47±13 months, 122 patients died; 58
of the deaths were cardiovascular and 33 were SCD.
In Cox regression analysis after adjustment for the
peak level of the variable under assessment, age, sex,
use of b-blockers, previous myocardial infarction
and other common coronary risk factors, the hazard
ratio of the continuous variable RPPrecovery (in units
1000 mm Hgb.p.m.) was 0.85 (95% CI: 0.73–0.98) for
SCD, 0.87 (0.78–0.97) for cardiovascular mortality, and
0.87 (0.81 to 0.94) for all-cause mortality. SAPrecovery was
not a predictor of mortality. The relative risks of having
HRR below 18 b.p.m., a widely used cutoff point, were as
follows: for SCD 1.28 (0.59–2.81, ns), for cardiovascular
mortality 2.39 (1.34–4.26) and for all-cause mortality
2.40 (1.61–3.58). In conclusion, as a readily available
parameter, RPPrecovery is a promising candidate for a
prognostic marker.
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Introduction
An abnormal response of the autonomic nervous
system during and after an exercise stress test is
believed to be a marker of increased risk of death.
Autonomic imbalance is reflected in, for example,
the heart rate (HR) profile during and after exercise,
which has been shown to associate with all-cause or
cardiac mortality during follow-up.1–4 Furthermore,
short-term regulation of blood pressure
(BHR stroke volumeperipheral resistance) is
dominated by the autonomic nervous system, and
the levels of and changes in systolic arterial pressure
(SAP) during the exercise have been found to
represent determinants of cardiovascular mortality
in several studies.5,6 Moreover, the recovery of SAP
(SAPrecovery) from the peak to the post-exercise level
might mirror changes in the autonomic balance. In
that case, SAPrecovery could also prove valuable in
predicting mortality during follow-up, but earlier
studies on this hypothesis have been scarce.7–9
Several computed parameters have been derived
with the idea that they would integrate several
(patho) physiological markers or phenomena into a
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single variable. Such markers have not yet, however,
broken through into wide-scale clinical use. Rate
pressure product (RPP¼HRSAP) is a simple
calculatory parameter based on two variables regu-
lated by the autonomic nervous system. RPP is used
as an indicator of myocardial oxygen uptake and
coronary blood flow in the exercise test.10 Moreover,
resting and peak RPP during exercise have been
linked to cardiovascular mortality,6,11–18 but the
prognostic value of the recovery of RPP (RPPrecovery)
from the peak to the post-exercise level is unknown.
As a part of the Finnish Cardiovascular Study
(FINCAVAS), we evaluated the hypothesis that the
recovery of two readily available variables, SAP and
RPP, can be used to predict all-cause and cardiovas-
cular mortality, as well as sudden cardiac death




As described in the detailed study protocol of
FINCAVAS,19 all consecutive patients coming in
for a clinically indicated exercise stress test at
Tampere University Hospital and willing to partici-
pate in the study were recruited between October
2001 and December 2004. A total of 2029 patients
(1290 men and 739 women) with technically
successful storage of exercise test data were in-
cluded in the study (Tables 1 and 2). The main
indications for the exercise test were a diagnosis of
coronary heart disease (CHD, frequency 46%),
testing vulnerability to arrhythmia during exercise
(21%), evaluations of working capacity (18%) and
the adequacy of CHD treatment (16%), in addition to
obtaining an exercise test profile prior to an invasive
operation (13%) or after a myocardial infarction
(8%); some patients had more than one indication.
The study protocol was approved by the Ethical
Committee of the Tampere University Hospital
District (Finland), and all patients gave an informed
consent prior to the interview and measurements as
stipulated in the Declaration of Helsinki Principles.
Study flow
After an informed consent was signed, the medical
history of each patient was collected with a
computer-based questionnaire. Thereafter, the sub-
ject lay down in the supine position for 10 min. The
exercise test was performed using a bicycle ergo-
meter with electrical brakes.
During the test, HR was continuously recorded
with electrocardiography, whereas arterial pressure
was measured with a brachial cuff every 2 min. The
highest HR and SAP values during the exercise were
used in the calculation of RPPpeak. In the post-
exercise phase, HR and SAP in the sitting position
Table 1 Patient characteristics and exercise test variables for all participants according to the HRR cutoff point of 18 b.p.m. during the
first minute of recovery
HRRX18 b.p.m., n¼1498 HRRo18 b.p.m., n¼ 531 P-value
Mean s.d. Mean s.d.
Age (years) 55 13 63 12 0.00
BMI (kg/m2) 27 4 29 5 0.00
Weight (kg) 80 15 83 16 0.00
Height (cm) 171 9 171 9 0.05
HR at rest (b.p.m.) 63 11 66 13 0.00
HR at peak exercise (b.p.m.) 152 23 131 31 0.00
Reached HR of expected maximum (%) 81 13 73 16 0.00
HR at 4 min of the recovery (b.p.m.) 85 17 82 20 0.00
SAP at rest (mm Hg) 135 18 137 20 0.06
SAP at peak exercise (mm Hg) 197 28 180 29 0.00
SAP at 4 min of recovery (mm Hg) 141 21 144 21 0.02
Abbreviations: BMI, body mass index; HR, heart rate; HRR, heart rate recovery; SAP, systolic arterial pressure.
The P-values have been derived with the t-test for independent samples.
Table 2 Unadjusted percentage of women, frequency of b-blocker
use, as well as the prevalence of cardiovascular disease,
symptoms, risk factors and death for all participants according
to the HRR cutoff point of 18 b.p.m. during the first minute of
recovery
HRRX18 b.p.m. HRRo18 b.p.m. P-value
(%) (%)
Women 37 34 0.13
b-Blockers 53 72 0.00
Smoking 27 27 0.85
CHD 35 47 0.00
Prior MI 19 26 0.00
Hypercholesterolaemia 48 55 0.01
Diabetes 10 18 0.00
SCD 1 3 0.03
Cardiovascular death 2 6 0.00
All-cause death 4 13 0.00
Abbreviations: CHD, coronary heart disease; HRR, heart rate recovery;
MI, myocardial infarction; SCD, sudden cardiac death.
The P-values have been calculated with the w2 test.
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at 4 min post-exercise were used in the calcula-
tion of RPPpost-exercise. RPPrecovery was defined
as RPPpeakRPPpost-exercise. Similarly, SAPrecovery¼
SAPpeakSAPpost-exercise. HRR was calculated as an
HR difference at the peak level and 1 min after the
exercise.
Follow-up
Death certificates were received from the Causes of
Death Register maintained by Statistics Finland in
May 2007; this source has been proven reliable.20
The certificates included causes of death using the
10th revision of the International Classification of
Diseases (ICD-10). The diagnosis numbers and
certificate texts were used to classify the deaths
as all cause, cardiovascular and SCDs (defined
as a cardiac death within 24 h after the onset of
symptoms).
Statistical analysis
An HRR cutoff point of 18 b.p.m. within the first
minute has been suggested by several authors for
exercise tests with an abrupt end.4.We used the same
cutoff point in addition to handling HRR as a
continuous variable. Because no previous cutoff
points for the decline in SAP and RPP have been
published, we used SAPrecovery and RPPrecovery only as
continuous variables.
The t-test for independent samples was used to
compare continuous patient characteristics and
exercise test variables between those with normal
and abnormal recovery values (Table 1), and the w2
test was applied for dichotomous variables (Table 2).
The hazard ratios and relative risks implied by
recovery values with regard to all-cause and cardi-
ovascular deaths, as well as SCD were estimated
with a Cox proportional hazards model using the
following covariates: the peak level of the variable
under assessment, sex, age, body mass index (BMI),
daily smoking (no/yes), use of b-blockers (no/yes),
prior diagnoses of CHD (no/yes), myocardial infarc-
tion (no/yes), diabetes (no/yes) and hypercholester-
olaemia (no/yes). The statistical analyses were
performed with the SPSS release 14.0 for Windows
(SPSS Inc, Chicago, IL, USA). All statistical tests
were two-tailed and used an a-level of o0.05.
Results
During the follow-up period of 47±13 months
(mean±s.d.), there were 122 deaths (6.0% of the
population), 58 (2.9%) of which were classified
as cardiovascular deaths and 33 (1.6%) further as
SCD (Figure 1). Patient characteristics, exercise test
variables and the number of deaths for those with
HRR X18 b.p.m. (n¼ 1498) and HRR o18 b.p.m.
(n¼ 531) are given in Tables 1 and 2.
Mortality and recoveries in HR, SAP and RPP
In Cox regression with adjustments for the peak
level of the variable to be assessed, sex, age, BMI,
smoking, use of b-blockers, and prior diagnoses of
CHD, myocardial infarction, diabetes and hyperch-
olesterolaemia, the hazard ratios of the continuous
variable RPPrecovery (in units 1000 mm Hg b.p.m.)
were statistically significant for all the three cate-
gories of death (Table 3). The continuous variable
SAPrecovery did not predict any type of mortality
(Table 4).
The relative risks of HRR when applying the
cutoff point of 18 b.p.m. were 1.28 for SCD (95%
confidence interval 0.59–2.81, P¼ 0.53), 2.39 for
Table 3 Adjusted hazard ratios and relative risks for sudden cardiac, cardiovascular and all-cause death in the Cox regression models
with RPPrecovery
SCD Cardiovascular mortality All-cause mortality
RR 95% CI P-value RR 95% CI P-value RR 95% CI P
Lower Upper Lower Upper Lower Upper
RPPrecovery (1000 b.p.m. per mm Hg) 0.85 0.73 0.98 0.02 0.87 0.78 0.97 0.01 0.87 0.81 0.94 o0.001
RPPpeak (1000 b.p.m. per mm Hg) 1.03 0.91 1.16 0.64 1.01 0.92 1.10 0.86 1.02 0.96 1.08 0.51
Age (years) 0.99 0.96 1.03 0.60 1.02 0.99 1.05 0.13 1.04 1.02 1.06 0.00
Sex (M/F) 0.14 0.03 0.60 0.01 0.35 0.17 0.73 0.01 0.55 0.36 0.84 0.01
BMI (kg/m2) 0.95 0.87 1.03 0.21 0.94 0.88 1.00 0.05 0.94 0.89 0.98 0.00
Smoking (no/yes) 1.08 0.49 2.38 0.84 0.85 0.47 1.53 0.59 0.64 0.43 0.96 0.03
Diabetes (no/yes) 0.68 0.28 1.63 0.39 0.69 0.37 1.30 0.26 0.80 0.51 1.28 0.36
b-Blocker (no/yes) 0.49 0.15 1.58 0.23 0.51 0.23 1.17 0.11 0.83 0.52 1.33 0.43
CHD (no/yes) 1.02 0.36 2.88 0.97 1.09 0.51 2.34 0.82 1.66 0.98 2.81 0.06
Prior MI (no/yes) 0.57 0.22 1.46 0.24 0.56 0.28 1.12 0.10 0.60 0.35 1.02 0.06
Hypercholesterolaemia (no/yes) 0.88 0.42 1.85 0.73 1.43 0.84 2.42 0.18 1.22 0.84 1.75 0.29
Abbreviations: BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; F, female; RR, hazard ratio/relative risk; M, male; MI,
myocardial infarction; RPPpeak, peak rate–pressure product during exercise; RPPrecovery, recovery of rate–pressure product; SCD, sudden cardiac
death.
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cardiovascular mortality (1.34–4.26, P¼ 0.003) and
2.40 for all-cause mortality (1.61–3.58, Po0.001).
HRR as a continuous variable produced a significant
hazard ratio for all-cause mortality 0.971 (0.954–
0.988, Po0.001), but not for cardiovascular (0.987
0.961–1.013, P¼ 0.32) or sudden cardiac (0.981,
0.949–1.015, P¼ 0.27) mortality.
Discussion
The exercise stress test is a routine tool in the
diagnostics and follow-up of CHD, as well as in
determining cardiovascular status prior to a major
procedure. In addition, the merits of the exercise test
as a prognostic means have been increasingly
recognized during the last two decades.21 It remains
a continuous challenge to develop new approaches
and enhance the existing techniques to screen large
general cardiovascular patient populations—not
only those at a particularly high risk—for increased
risk of cardiac death. Because the exercise stress test
is a widespread and relatively inexpensive tool, it
will be of special interest if the applicability of the
test can be expanded from evaluating the prevailing
cardiovascular status to cardiovascular prognosis.
Several markers of vagal tone and autonomic
imbalance at rest have been connected to cardiovas-
cular events and mortality: elevated resting HR,
impaired HR variability, decreased baroreflex sensi-
tivity,22,23 and so on. During exercise, HR and SAP
increase steadily because of the gradual activation of
the sympathetic and concomitant deactivation of
parasympathetic nervous system. HRR after exercise
is considered to be a function of the reactivation of
the parasympathetic nervous system, which is
important primarily during the first minute after
exercise. HRR has been used as a predictor of overall
and cardiovascular mortality in studies with various
types of patients: healthy subjects and those with or
without CHD.1,3,8,24 Our unselected hospital popula-
tion that comprises consecutive patients coming in
for a clinically indicated clinical exercise test
repeated this finding when using the cutoff point
of 18 b.p.m. at 1 min after an abrupt discontinuation
of the exercise.
Poor decrease of SAP after the exercise has been
linked to CHD or the severity of myocardial
ischaemia,25,26 stroke27 and myocardial infarction,28
but the previous studies on mortality have yielded
conflicting results. In one of these previous studies,
abnormal post-exercise SAP response stratified the
all-cause mortality in patients (n¼ 217) after an
acute myocardial infarction.9 However, two other
studies, with either 12 379 low-risk7 or 2428 con-
secutive adult patients,8 did not support this
finding, which is consistent with our results: we
did not find an association between SAPrecovery and
overall, cardiovascular or sudden cardiac mortality.
Given the impact of the large studies, SAPrecovery
does not seem to be applicable in risk stratification.
The peak-level SAP reached significance for all-
cause mortality: the higher the peak SAP, the lower
the risk of death. This has also been found in earlier
reports,29 suggesting that better trained subjects
exhibit a higher SAP response to exercise.29
To the best of our knowledge, this is the first
report of the value of RPPrecovery in prognostics.
Because no previous cutoff points were available,
we used only RPPrecovery as a continuous variable.
This parameter had an inverse relation with all three
types of end points used: the greater the drop in
RPP, the lower the risk of death. This is clearly
supported by Figure 1, where the prevalence of
death is clearly higher in the quintile with lowest
than highest RPPrecovery. It deserves to be mentioned
Table 4 Adjusted hazard ratios and relative risks for sudden cardiac, cardiovascular and all-cause death in the Cox regression models
with SAPrecovery
SCD Cardiovascular mortality All-cause mortality
RR 95% CI P-value RR 95% CI P-value RR 95% CI P-value
Lower Upper Lower Upper Lower Upper
SAPrecovery (mm Hg) 0.99 0.97 1.01 0.28 0.99 0.97 1.00 0.15 0.99 0.98 1.00 0.21
SAPpeak (mm Hg) 0.99 0.97 1.01 0.21 0.99 0.97 1.00 0.08 0.99 0.98 1.00 0.01
Age (years) 1.00 0.97 1.04 0.86 1.03 1.01 1.06 0.01 1.05 1.03 1.07 0.00
Sex (M/F) 0.18 0.05 0.61 0.01 0.33 0.17 0.67 0.00 0.50 0.33 0.77 0.00
BMI (kg/m2) 0.98 0.90 1.06 0.58 0.96 0.90 1.02 0.20 0.95 0.91 0.99 0.03
Smoking (no/yes) 0.96 0.45 2.04 0.91 0.82 0.46 1.44 0.48 0.64 0.44 0.95 0.02
Diabetes (no/yes) 0.66 0.28 1.59 0.36 0.69 0.37 1.30 0.26 0.76 0.47 1.20 0.24
b-Blocker (no/yes) 0.44 0.14 1.38 0.16 0.46 0.20 1.02 0.05 0.78 0.49 1.23 0.28
CHD (no/yes) 0.99 0.36 2.72 0.98 1.08 0.51 2.29 0.83 1.59 0.94 2.69 0.08
Prior MI (no/yes) 0.61 0.24 1.58 0.31 0.58 0.29 1.18 0.14 0.62 0.37 1.06 0.08
Hypercholesterolaemia (no/yes) 0.87 0.41 1.81 0.70 1.47 0.88 2.46 0.15 1.25 0.87 1.80 0.22
Abbreviations: BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; F, female; RR, hazard ratio/relative risk; M, male; MI,
myocardial infarction; SAPpeak, peak systolic arterial pressure during exercise; SAPrecovery, recovery of systolic arterial pressure; SCD, sudden
cardiac death.
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that RPPrecovery emerged as the sole haemodynamic
parameter with a statistically significant hazard
ratio for SCD. There are many possible mechanisms
to explain why delayed decrease in RPP after the
exercise would be an indicator of increased mortal-
ity. Both HR and blood pressure are adjusted by
several mechanisms, but the autonomic nervous
system is the dominant regulator in acute changes.
Autonomic dysfunction or abnormalities in vasor-
eactivity may thus cause low RPPrecovery. Moreover,
RPPrecovery may reflect aerobic capacity and physical
fitness, which have been linked to prognosis.
Because we used no cutoff points for RPP or SAP,
the demographic data presented are divided by
HRR at 18 b.p.m. The groups with HRR of at least
18 b.p.m. and o18 b.p.m. differ from each other
regarding several known cardiovascular risk factors
(Tables 1 and 2). Therefore, we used many covariates
to clarify the importance of each of these risk factors
as determinants of poorer prognosis (Table 3). In the
models with RPPrecovery, sex and RPPrecovery were the
only statistically significant independent risk factor
for SCD and cardiovascular death, whereas BMI, age
and smoking status appeared as significant covari-
ates in addition to RPPrecovery and sex for all-cause
mortality. Surprisingly, age was a prognostic marker
only for all-cause mortality. This is probably due to
the duration of follow-up. Smoking and BMI had a
paradoxical negative association with all-cause
mortality; however, smoking and BMI had a positive
link to mortality if they were the only covariates in
the model.
One disparity between our study groups was the
use of b-blockers (Table 2). Medication with the
b-blockers causes reduced increase in HR and SAP,
and thus reduced maximal RPP. The medication
status upon the exercise test depends on the
indication the test is performed for. Our patients
with a clinically indicated exercise test were tested,
for example, to evaluate working capacity (18% of
the tests) and the adequacy of CHD treatment (16%).
These tests are performed with the prevailing
medications, whereas those tested for CHD diag-
nostics (46%) enter the test after discontinuing their
b-blockers for at least 5 days. We used the b-blocker
status as a covariate in the Cox regression analyses,
but it did not prove to be a significant risk factor in
any of the models.
The standard exercise stress test with a bicycle
has certain advantages compared with treadmill
tests.10,30 One of these is the easier measurement of
blood pressure during exertion. On the other hand,
the present study is subject to some limitations.
We included all patients scheduled for a clinical
exercise stress test at a university setting, and the
population comprises patients with a wide spec-
trum of ages, life styles, histories and statuses of
cardiac disease. The impact of the heterogeneity is
diminished if not eliminated by using several
covariates in the analysis.
In conclusion, the readily available parameter
RPPrecovery is a promising candidate for a prognostic
marker. The validity of this variable needs to be
tested further in other exercise stress test popula-
tions, before a more widespread clinical use of the
markers can be recommended. SAPrecovery does not
seem to serve as a prognostic tool.
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What is known about the topic
K Levels of and changes in systolic arterial pressure and heart
rate during an exercise test are associated with mortality.
K Suppressed heart rate recovery, an index of parasympathetic
re-activation after the exercise phase, is a predictor of
mortality.
K Peak rate–pressure product (heart rate systolic arterial
pressure) during exercise is a prognostic marker.
What this study adds
K Recovery of rate–pressure product after the exercise phase
is linked to cardiovascular and all-cause mortality, as well as
sudden cardiac death independently of traditional risk
factors.
K Recovery in systolic arterial pressure is not associated with
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Figure 1 Prevalence (%) of unadjusted all-cause and cardiovas-
cular (CVD) mortality, as well as sudden cardiac death (SCD) for
the RPPrecovery quintiles.
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